An LC-MS-MS method for the determination of indinavir, an HIV-1 protease inhibitor, in human plasma

Journal of Pharmaceutical and Biomedical Analysis

Volumn 25, Issue 2, 2001, Pages 309-317

  Jayewardene, Anura L ^a   Kearney, Brian ^b   Stone, Judith A ^a   Gambertoglio, John G ^a   Aweeka, Francesca T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GILEAD SCIENCES   (United States)

Author keywords

HIV 1; Indinavir; LC MS MS; Protease inhibitor

Indexed keywords

1 738804; ACETONITRILE; DYE; INDINAVIR; ION; PLASMA PROTEIN; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ARTICLE; CALIBRATION; CENTRIFUGATION; CONTROLLED STUDY; DRUG DETERMINATION; DRUG STRUCTURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIQUID CHROMATOGRAPHY; PLASMA; PRECIPITATION; PRIORITY JOURNAL; STANDARD; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS;

CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HIV PROTEASE INHIBITORS; HUMANS; INDINAVIR; MASS SPECTROMETRY; QUALITY CONTROL; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SOLUTIONS;

EID: 0035085408     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(00)00506-9     Document Type: Article

References (11)